1Andre TB,Cecelia HB,Jacqueline ML et al.Soluble Epidermal Growth Factor Receptor (SEG-FR) and Cancer Antigen 125 (CA125) as Screening and Diagnostic Test for Epithelial Ovarian Cancer.Cancer Epidemiology,Biomarkers and Prevention.2005,14(2):306 被引量：1
2Moss EL,Hollingworth J,Reynolds TM,The role of CA125 in clinical practice.Clinical Pathology.2005 Mar,58 (3):308 被引量：1
3Einhorn N,Knapp RC,Bast RC et al:CA125 assay used in conjunction with CA15 -3 and TAG -72 assays for discrimination between malignant and non-malignant diseases of the ovary.Acta Oncol.1989,28:655 被引量：1
4Gronlund B,Hogdall C,Hilden J et al.Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RE-CIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma? Clinical Oncology,2004,22 (20):4051 被引量：1
5Borras G,Molina R,Xereavins J et al.Tumor antigens CA19 -9,CA125,and CEA in carcinoma of the uterine cervix.Gynecol Oneology,1995,57 (2):205 被引量：1
6Filella X,Friese S,Roth HJ et al.Technical pertormance of the Elecsys (R) CA72 -4test:Development and field study.Anticacer Res,2000,20:5229 被引量：1
7Kim YT,Yoon BS,Kim JW,Kim SH et al.Carcinoma antigen and urine squamous cell carcinoma antigen and urine polyamines in women with squamous cell carcinoma of the cervix.International Gynaecology and Obstetrics,2005,91 (1):47 被引量：1
8Takeshima N,Harai Y,Katase K et al.The value squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.Gynecology Oncol,1998,68 (3):263 被引量：1
9Healy DL,Burger HG,Bouma M et al.Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.N Engle J Med,1993,329:1539 被引量：1
5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin. 2008, 58(2): 71-96. 被引量：1
6Wang R, Lin F, Wang X, et al. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression[J]. Cancer Biol Ther 2007, 6 (1): 295-301. 被引量：1
7Nagai N, Oshita T, Murakni J, et al. Semiquantitive analysis oftelomerase activity in cervical cancer and precancerous lesions [J]. J Oncol Rep, 1999, 6 : 325-328. 被引量：1
8Hese!meyer-Haddad K, Janz V, Castle PE, et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia[J]. Am J Pathol, 2003, 163:1405-1416. 被引量：1
9Prendiville W, Ritter J, Tatti S, Twiggs L. Management del Pap test anormale. Linee guida della SICPCV. In Colposcopy management options[J]. Elsevier Italia; 2005. p. 205. 被引量：1
10Janedrkova N, Krkavcova M, Janashia AL. Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors [J]. Ceska Gynekol, 2008, 73(2): 79-86. 被引量：1
